Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share Price

Price 14,100.00p on 30-06-2026 at 18:13:58
Change -198.00p -1.38%
Buy 14,154.00p
Sell 14,152.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Unknown 0.00 at 14,286.58297p
Day's Volume: 2,512,929
Last Close: 14,100.00p
Open: 14,356.00p
ISIN: GB0009895292
Day's Range 14,054.00p - 14,536.00p
52wk Range: 10,112.00p - 15,730.00p
Market Capitalisation: £218.67b
VWAP: 14,200.67173p
Shares in Issue: 1.55b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Lower Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Astrazeneca (AZN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 0 14,286.58297p SI Trade
Currency Conversion
 19:13:58 - 30-Jun-26
Unknown* 0 14,287.33859p Currency Conversion
OTC Trade
 19:09:53 - 30-Jun-26
Unknown* 0 14,234.44491p SI Trade
Currency Conversion
 18:48:59 - 30-Jun-26
Unknown* 0 14,242.00115p SI Trade
Currency Conversion
 18:46:38 - 30-Jun-26
Unknown* 0 14,245.02365p SI Trade
Currency Conversion
 18:46:17 - 30-Jun-26
Unknown* 0 14,248.80177p SI Trade
Currency Conversion
 18:31:54 - 30-Jun-26
Unknown* 0 14,248.80177p SI Trade
Currency Conversion
 18:31:54 - 30-Jun-26
Unknown* 20 14,248.80177p Currency Conversion
OTC Trade
 18:30:59 - 30-Jun-26
Unknown* 0 14,235.20054p Currency Conversion
OTC Trade
 18:15:14 - 30-Jun-26
Unknown* 0 14,235.20054p Currency Conversion
OTC Trade
 18:15:14 - 30-Jun-26
See more Astrazeneca trades

Astrazeneca (AZN) Share Price History

Time period:
to
Date Open High Low Close Volume
30th Jun 2026 (Tue) 14,356.00 14,536.00 14,054.00 14,100.00 2,512,929
29th Jun 2026 (Mon) 14,364.00 14,386.00 14,200.00 14,298.00 1,883,313
26th Jun 2026 (Fri) 14,038.00 14,326.00 13,900.00 14,318.00 3,945,847
25th Jun 2026 (Thu) 13,862.00 14,134.00 13,786.00 14,062.00 1,790,523
24th Jun 2026 (Wed) 13,588.00 14,018.00 13,584.00 13,910.00 2,775,862
23rd Jun 2026 (Tue) 13,388.00 13,706.00 13,342.00 13,590.00 1,872,524
22nd Jun 2026 (Mon) 13,240.00 13,340.00 13,198.00 13,290.00 1,820,566
19th Jun 2026 (Fri) 13,284.00 13,396.00 13,156.00 13,234.00 4,454,518
18th Jun 2026 (Thu) 13,482.00 13,506.00 13,116.00 13,154.00 1,591,007
17th Jun 2026 (Wed) 13,332.00 13,472.00 13,272.00 13,472.00 1,420,398
16th Jun 2026 (Tue) 13,248.00 13,320.00 13,172.00 13,284.00 4,260,476
15th Jun 2026 (Mon) 13,462.00 13,530.00 13,172.00 13,200.00 1,817,432
12th Jun 2026 (Fri) 13,606.00 13,784.00 13,380.00 13,462.00 2,094,417
11th Jun 2026 (Thu) 13,432.00 13,680.00 13,392.00 13,578.00 2,231,423
10th Jun 2026 (Wed) 13,730.00 13,730.00 13,376.00 13,464.00 1,761,852
9th Jun 2026 (Tue) 13,632.00 13,716.00 13,486.00 13,632.00 1,908,520
8th Jun 2026 (Mon) 13,812.00 13,878.00 13,708.00 13,796.00 1,740,949
5th Jun 2026 (Fri) 13,592.00 13,864.00 13,588.00 13,858.00 1,729,406
4th Jun 2026 (Thu) 13,170.00 13,594.00 13,168.00 13,554.00 1,556,393
3rd Jun 2026 (Wed) 13,082.00 13,210.00 12,706.00 13,210.00 2,600,008
2nd Jun 2026 (Tue) 13,432.00 13,444.00 13,132.00 13,214.00 1,916,142
1st Jun 2026 (Mon) 13,702.00 13,724.00 13,380.00 13,434.00 1,397,982
See more Astrazeneca price history

Astrazeneca (AZN) Regulatory News

Date Source Headline
29th Jun 2026 7:30 am RNS Enhertu approved in EU for HER2+ solid tumours
29th Jun 2026 7:00 am RNS Datroway recommended for approval in EU for TNBC
15th Jun 2026 7:00 am RNS Truqap approved in US for prostate cancer
1st Jun 2026 3:05 pm RNS Admission of Further Securities to Trading
1st Jun 2026 3:00 pm RNS Total Voting Rights
29th May 2026 7:00 am RNS Imfinzi approved in US for early bladder cancer
27th May 2026 7:00 am RNS US FDA decision date on camizestrant extended
26th May 2026 7:00 am RNS Enhertu recommended in EU for HER2+ solid tumours
26th May 2026 7:00 am RNS Camizestrant recommended for breast cancer in EU
26th May 2026 7:00 am RNS Datroway approved in US for 1L triple-negative BC
See more Astrazeneca regulatory news

Astrazeneca (AZN) Share News

AstraZeneca's Enhertu wins first EU tumour-agnostic approval for HER2

29th Jun 2026 08:38

(Alliance News) - AstraZeneca PLC on Monday said the European Commission has approved Enhertu as the first tumour-agnostic HER2-directed therapy and antibody drug conjugate in the EU for previously treated patients with HER2-positive metastatic solid tumours. Read More

LONDON BRIEFING: BT, Verizon merge international arms in joint venture

29th Jun 2026 07:57

(Alliance News) - BT and Verizon form international joint venture, Foresight increases its dividend while Plus500 adds to its US prediction markets offering with sports event-based contracts. Read More

AstraZeneca's, Daiichi's Datroway recommended for further EU approval

26th Jun 2026 12:32

(Alliance News) - AstraZeneca PLC on Friday said the Committee for Medicinal Products for Human Use of the European Medicines Agency recommended approval of Datroway for a form of breast cancer. Read More

LONDON MARKET CLOSE: Miners peg back FTSE 100 while mid-caps struggle

23rd Jun 2026 16:59

(Alliance News) - The FTSE 100 edged lower on Tuesday held back by weak miners, while fresh US tech falls and soft UK economic data added to the muted mood. Read More

WINNERS & LOSERS: Telecom Plus cuts dividend, warns on profit

23rd Jun 2026 09:58

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday. Read More

See more Astrazeneca news
FTSE 100 Latest
Value10,497.12
Change12.90

Login to your account

Forgot Password?

Not Registered